Year In Review: FDA Spotlights Social Media, But No Guidelines Yet
Executive Summary
As drug makers await feedback from FDA on the use of the Internet and newer technologies for drug promotion, more are warming to the idea that unbranded campaigns in these media are the safest bet, for now